Blueshift Asset Management’s United Therapeutics UTHR Stock Holding History

Blueshift Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$255K	Buy	+471	New	+$265K	0.06%	423
2025 Q3	–	Sell	-2,496	Closed	-$717K	–	625
2025 Q2	$717K	Buy	2,496 +799	+47%	+$239K	0.22%	118
2025 Q1	$523K	Buy	+1,697	New	+$582K	0.21%	148
2024 Q1	–	Sell	-1,983	Closed	-$436K	–	380
2023 Q4	$436K	Buy	+1,983	New	+$457K	0.23%	126
2023 Q3	–	Sell	-1,458	Closed	-$322K	–	433
2023 Q2	$322K	Buy	1,458 +42	+3%	+$9.3K	0.12%	205
2023 Q1	$317K	Buy	+1,416	New	+$349K	0.13%	212
2021 Q4	–	Sell	-3,924	Closed	-$724K	–	1237
2021 Q3	$724K	Buy	3,924 +1,202	+44%	+$237K	0.04%	512
2021 Q2	$488K	Buy	+2,722	New	+$518K	0.03%	573
2019 Q3	–	Sell	-5,203	Closed	-$406K	–	972
2019 Q2	$406K	Buy	+5,203	New	+$487K	0.05%	455

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Blueshift Asset Management's UTHR Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 471 shares worth $255K. The stake represents 0.06% of the portfolio and ranks #423 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in UTHR as recently as Q2 2025.

Blueshift Asset Management first reported a position in UTHR in Q2 2019 and has held it in 9 quarters since. The position peaked at $724K in Q3 2021. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Blueshift Asset Management held 471 shares of United Therapeutics worth $255K as of Q2 2026.
United Therapeutics was a new Blueshift Asset Management position in Q2 2026.
United Therapeutics made up 0.06% of Blueshift Asset Management's portfolio in Q2 2026, its #423 holding.
Blueshift Asset Management first reported a position in United Therapeutics in Q2 2019 and has held it in 9 quarters since.
Blueshift Asset Management's United Therapeutics position peaked at $724K in Q3 2021.
884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.